How AI Agents Will Change Research

A small startup team can now investigate a market, compare competitors and summarize findings in a single afternoon. Artificial intelligence (AI) agents are making it more realistic to do both, going beyond chatbots to handle multi step research tasks that previously required dedicated analysts or expensive consultants. This article looks at what makes AI agents different from other AI tools, how they're changing research workflows and what that shift means for startup teams running lean.

What Makes AI Agents Different From Other AI Tools

An AI agent differs from a standard chatbot in how it operates. A chatbot takes a prompt and returns a response. An agent takes a goal and figures out how to achieve it across multiple steps. It can use external tools, maintain memory and adapt when things go wrong.

How Agents Plan and Execute Multi Step Tasks

AI agents operate through a cycle of planning, acting and learning. They interpret a complex goal, reason through actionable steps, execute those steps with external tools and then refine their approach based on what they find. Modern agents can decompose complex goals into manageable subgoals, identify task dependencies and adapt plans as circumstances change through agent architecture that coordinates reasoning with action. A chatbot answers questions one at a time. An agent can pull competitor pricing from a webpage, run a statistical comparison and draft a summary memo in sequence without a human touching it between steps.

Why Multi Agent Systems Can Tackle Research Across Disciplines

An AI agent is a system where large language models autonomously use tools in a loop. The most powerful implementations go further by coordinating multiple specialized agents rather than relying on a single model. One agent might handle literature search, while another screens for relevance and a third synthesizes findings. This kind of architecture differs from single-model chatbots designed primarily for conversational interactions.

Where the Current Limitations Still Sit

Current agent limitations create operational risk in research workflows. Agents still struggle with long-horizon complex tasks that require extensive multi step reasoning. As more agents get deployed, each one can build its own fragment of truth and data inconsistency at scale produces real business consequences. Newer reasoning systems from major AI labs are actually more error prone than their predecessors, even as their math skills improve. Agents will confidently state wrong things without expressing uncertainty, which means human verification remains non-negotiable for any claim that influences a real decision.

How AI Agents Are Changing Research Workflows

AI agents are starting to reshape how teams collect, analyze and act on information. The efficiency gains are not incremental and the examples below show where agents deliver measurable advantages in literature-related and hypothesis-oriented workflows compared with manual effort alone.

• Automating Literature Review at Scale

Literature review is where agents show one of the clearest documented improvements. Recent research in biomedical AI has explored how multi agent systems can accelerate dry-lab research cycles, though reported speedup figures vary widely depending on the specific workflow and architecture. Specialization explains the performance gap: instead of one model doing everything, separate agents handle search, screening and synthesis in parallel. For technical founders, a multi-agent pipeline running in parallel outperforms a single powerful model running sequentially and this architecture is buildable today with existing frameworks.

• Shifting Data Analysis From Periodic to Continuous

Traditional research follows a batch cycle of running experiments, waiting, analyzing and repeating. AI agents remove many of those wait states. Modular tools support natural human-instrument interaction at scientific user facilities and support continuous data collection alongside real time analysis. In chemistry, a fine-tuned model identified reaction conditions in 15 experimental runs, a result that saved researchers hundreds of trials and weeks of work. The closed-loop architecture, where instruments feed data to agents that adjust parameters and trigger the next experiment, compresses the time between cycles from days to minutes.

• Generating and Testing Hypotheses From Existing Data

AI agents can now generate novel hypotheses, not analyze existing ones alone. Systems in the current research wave have reproduced insights that took human teams far longer to reach. These are exploratory ideas requiring human validation, not finished research, but the speed at which agents can surface promising directions changes how teams allocate their attention.

Where AI Agents Are Having the Biggest Impact

Two verticals show the strongest evidence of AI agents changing research outcomes. The maturity and documentation quality vary between them, but both reveal distinct patterns in how agents create value and where skepticism remains warranted.

Drug Discovery and Clinical Research

Drug discovery remains in a show-me phase with AI agents. AI-derived drug patents demonstrate scientific progress, with distinctiveness in both targets and molecular structures. Insilico Medicine has used agent-driven approaches to accelerate drug discovery timelines for conditions including fibrosis. Analysts project the AI drug discovery market will grow from $1.8 billion in 2023 to $13.1 billion by 2034.

The economics reveal caution: while AI partnerships announced over $15 billion in potential deal value during 2025, actual upfront payments represented only two percent of those headlines. For founders building in biotech AI, the validation gap itself is the product opportunity. Tools that help pharma companies establish reproducible, auditable evidence of AI agent impact will be in demand when the first major clinical proof points arrive.

Market Research and Competitive Intelligence

AI agents are already in production for market research and competitive intelligence. AI startup investment continued to grow in 2024, and tools like Abacus DeepAgent now track competitor websites and generate weekly intelligence reports autonomously. At CRV, an early stage venture capital firm, we see this shift up close through startups that build and use AI-powered infrastructure.

CRV led Mercury's Series A and participated in its Series B and C. CRV led Vercel's Series A and backed the company through its B, C, D and E rounds. CRV holds board seats at both Mercury and Vercel. Vercel released AI Software Development Kit (SDK) 6 with a dedicated agent abstraction and a marketplace for production ready agents. Those building blocks let developers create research and analysis workflows without starting from scratch and the gap between enterprise intent to deploy agents and capability to deploy well is where technical founders can win right now.

What This Means for Startup Teams

The practical question for founders isn't whether AI agents will change research. It's how to use them effectively with a small team and limited budget. Teams of two to three people are already doing this, but it requires experienced practitioners, narrow scope to start and rigorous oversight from day one.

How Smaller Teams Can Now Run Research at Scale

Small teams are already showing what's possible. MOVEdot built sensor agents for hardware engineering data analysis with a team of 10. E2B provides agent sandbox infrastructure for sandboxed AI coding environments. Large in-house engineering teams at companies like Coinbase and Ramp used to build that kind of infrastructure. Starting narrow and proving value before scaling complexity is the pattern that works and more complex multi-agent systems usually require materially more investment and operational overhead than single-task agents.

Where Human Oversight Still Belongs

Human oversight isn't optional and underinvesting in it is one of the most common mistakes founders make with agents. Three areas demand mandatory human involvement:

• Factual claim verification: Any factual claim that influences a decision needs source checking because agents will confidently present incorrect information without flagging uncertainty.
• Regulated industry outputs: Fintech, health and cybersecurity outputs require audit logs and source traceability as table stakes.
• High-consequence decisions: Anything with significant downstream consequences needs a human positioned to monitor and intervene before actions take effect.

The right oversight model isn't approving every agent action. The better oversight model builds monitoring infrastructure that tracks confidence, so humans can step in when something goes wrong. These checkpoints keep human review focused on high-risk moments instead of slowing every action. That balance makes agent workflows usable in practice.

How to Think About AI Agents as Research Infrastructure

AI agents work best when you treat them as infrastructure rather than magic. CRV led DoorDash's first financing round and backed the company again during its Series A and B. Today, DoorDash operates an internal AI system that evolved from deterministic workflows to dynamic multi-agent systems for complex data tasks. Most companies will move from simple automation to coordinated agent teams over time. The version you build in a weekend isn't the version that runs in production, so teams should build observability from day one and treat agent actions as auditable infrastructure rather than black-box automation.

What the Shift to Agentic Research Means for How You Build

The founders who will benefit most from AI agents in research are the ones who start with a specific, narrow problem and build disciplined oversight into their workflow from the beginning. Agentic research is mature enough to deliver real results today, but execution quality is everything. Gartner projects companies will cancel over 40 percent of projects involving agentic AI by the end of 2027, mostly due to shallow implementation and lack of clear return on investment (ROI). The teams that treat agents as serious infrastructure rather than a quick experiment will be the ones that pull ahead.

Agentic research infrastructure is the kind of compounding advantage that separates great teams from the rest and at CRV, we back the technical founders who build it out of necessity rather than hype. If you're an early stage founder looking for support building AI research infrastructure, reach out to us to see if we'd be a good fit.

Frequently Asked Questions

What is the difference between an AI agent and a regular AI chatbot?

A chatbot takes a single prompt and returns a single response. An AI agent takes a goal and autonomously plans, executes and adapts across multiple steps. Agents call application programming interfaces (APIs), run code, search databases and pipe results back into their reasoning loop without human intervention at each step. In practice, most production deployments still operate within human-defined boundaries rather than as fully unconstrained autonomous systems.

Can AI agents replace human researchers?

AI agents accelerate specific research tasks like literature synthesis, data analysis and hypothesis generation, but they can't replace human researchers entirely. Agents still struggle with long-horizon reasoning and frequently present incorrect information with high confidence. The most effective model pairs agents with humans who monitor outputs and intervene at high-risk decision points.

How are startups using AI agents in their research workflows today?

Small startup teams are using AI agents for competitive intelligence monitoring, automated literature review, continuous data analysis and hypothesis exploration. Startups like E2B and MOVEdot are building agent systems that expand what small teams can deliver. The common pattern is starting with a single specialized agent for one high-value task, proving ROI and then expanding scope gradually rather than attempting broad multi- agent deployments from day one.

What risks should teams consider before adopting AI agents?

The primary risks are factual errors, compounding mistakes in multi agent coordination, reproducibility challenges and shallow implementation. Agents will confidently state wrong things without expressing uncertainty and when multiple agents pass information to each other, errors can amplify. Teams should also know that many claimed agent capabilities are still immature, so building observability and audit infrastructure from day one is necessary for catching problems before they affect downstream decisions.

‍